. 2019 Feb 7;23(4):2813–2821. doi: 10.1111/jcmm.14189
© 2019 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.
This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Figure 5.
miR‐128 inhibited PI3K/AKT and ERK signalling pathway activity